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Abstract For more than two decades, prenatal care has been
a cornerstone of our nation’s strategy for improving preg-
nancy outcomes. In recent years, however, a growing recog-
nition of the limits of prenatal care and the importance of ma-
ternal health before pregnancy has drawn increasing attention
to preconception and internatal care. Internatal care refers to
a package of healthcare and ancillary services provided to a
woman and her family from the birth of one child to the birth
of her next child. For healthy mothers, internatal care offers
an opportunity for wellness promotion between pregnancies.
For high-risk mothers, internatal care provides strategies for
risk reduction before their next pregnancy. In this paper we
begin to define the contents of internatal care. The core com-
ponents of internatal care consist of risk assessment, health
promotion, clinical and psychosocial interventions. We iden-
tified several priority areas, such as FINDS (family violence,
infections, nutrition, depression, and stress) for risk assess-
ment or BBEEFF (breastfeeding, back-to-sleep, exercise, ex-
posures, family planning and folate) for health promotion.
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Women with chronic health conditions such as hyperten-
sion, diabetes, or weight problems should receive on-going
care per clinical guidelines for their evaluation, treatment,
and follow-up during the internatal period. For women with
prior adverse outcomes such as preterm delivery, we propose
an internatal care model based on known etiologic pathways,
with the goal of preventing recurrence by addressing these
biobehavioral pathways prior to the next pregnancy. We sug-
gest enhancing service integration for women and families,
including possibly care coordination and home visitation for
selected high-risk women. The primary aim of this paper is
to start a dialogue on the content of internatal care.
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For more than two decades, prenatal care has been a cor-
nerstone of our nation’s strategy for improving pregnancy
outcomes. In recent years, however, the effectiveness of this
strategy has been called into question [1]. Increasing use of
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early and adequate prenatal care has not led to a significant
decline in low birthweight (LBW) or prematurity, which are
leading causes of infant mortality in the U.S.. Nor has closing
the access gap in prenatal care led to a significant reduction
in racial-ethnic or socioeconomic disparities in these adverse
birth outcomes. There is now a growing consensus that fur-
ther reduction in this nation’s LBW and prematurity rates
cannot be achieved solely by improving access to prenatal
care [2].
A limitation on the effectiveness of prenatal care may be
its timing. Many of the pathophysiological pathways leading
up to adverse birth outcomes may have their onset early in
pregnancy, possibly at or even before implantation. By the
time prenatal care is initiated, it may be too little too late to
significantly alter the course or outcome of the pregnancy.
Indeed, there is now a growing recognition that birth out-
comes are the end product of not only the nine months of
pregnancy, but the entire life course of the mother leading up
to the pregnancy [3]. Improving birth outcomes, therefore,
takes promoting maternal health not only during pregnancy,
but before and between pregnancies and, indeed, across the
woman’s lifespan.
The recognition of the importance of maternal health be-
fore pregnancy has led to a growing interest in preconcep-
tion care [4]. A special subtype of preconception care is
internatal care. Internatal care refers to a package of health-
care and ancillary services provided to a woman and her
family from the birth of one child to the birth of her next
child. It is, in essence, preconception and prenatal care for a
subsequent pregnancy. We prefer the term “internatal care”
over the more popular term “interconception care” (from the
conception of one pregnancy to the conception of the next
pregnancy) because 1) internatal care represents an exten-
sion of prenatal care with which the public is familiar; 2)
the point of entry into care is the birth of one child; and
3) the endpoint of care is the birth of the next child. And
while in this paper we will focus primarily on the interpreg-
nancy interval (from the termination of one pregnancy to
the conception of the next pregnancy), we prefer the term
“internatal care” over “interpregnancy care” because inter-
natal care suggests a continuity of care into a subsequent
pregnancy.
Despite the growing interest, for most people it remains
unclear what is meant by internatal care. For example, many
Healthy Start programs now offer internatal care, and yet
the content of care varies greatly across sites. There have
also been a few intervention studies on internatal care, most
notably in Denver [5], Atlanta [6], and Philadelphia [7], with
vastly different approaches. The lack of some standards of
care makes it difficult to move forward research, practice, and
policy, or even discussion, on internatal care. The purpose
of this paper is to begin to define the content of internatal
care.
For healthy mothers, internatal care offers an opportu-
nity for wellness promotion between pregnancies. Presently
many women lack such opportunity, particularly among low-
income and minority women. In most states, Medicaid pro-
grams terminate pregnancy-related healthcare coverage for
most low-income mothers at 60 days postpartum. Other
than the one recommended postpartum visit, many of these
women will have little or no access to healthcare between
pregnancies. Internatal care can help close the gap in health-
care for these women. Even for women with healthcare cov-
erage, it is unclear how much and what internatal care they
are currently getting. In this paper, we begin to define the
core contents of universal internatal care that all women of
childbearing age should receive between pregnancies.
While we believe that internatal care should be univer-
sally available to all women between pregnancies, it may be
particularly beneficial for high-risk mothers, such as women
with chronic diseases or prior adverse pregnancy outcomes.
Many such outcomes (e.g. prematurity, fetal death) carry
a high recurrence risk in a subsequent pregnancy, and the
biobehavioral risk factors are often carried from one preg-
nancy to the next [8]. For these mothers, internatal care
offers an opportunity for risk reduction before their next
pregnancy. In this paper, we also begin to describe the con-
tent of enhanced internatal care for high-risk mothers. We
will use women with chronic health conditions (hyperten-
sion, diabetes, or weight problems) and women with a prior
preterm delivery as examples of what more can be done
for high-risk mothers during internatal care than under cur-
rent prevailing practice which, for many women, consists of
the one recommended six-week postpartum visit, or none
at all.
Two decades ago, the U.S. Public Health Service as-
sembled an expert panel to define the contents of prena-
tal care. In its report Caring for Our Future: The Con-
tent of Prenatal Care, the Expert Panel identified four ba-
sic components of prenatal care consisting of 1) early and
continuing risk assessment, 2) health promotion, 3) clini-
cal interventions, and 4) psychosocial interventions [9]. We
now use the same framework to outline the contents of
internatal care, based on our search of the literature for
clinical standards, best practices, and proven or promis-
ing strategies. The focus of this paper is on the con-
tent of internatal care, particularly during clinical visits.
Other important topics, such as financing, organization,
delivery, motivation, and community interventions, are be-
yond the scope of this paper and will be addressed in a series
of papers to follow.
It is not our intention in this paper to propose a complete
and final model of internatal care. Instead, we present here
the start of a framework for internatal care, to be filled in
through more dialogues and consensus-building which we
hope this paper will help move forward.
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Recommended core contents of universal internatal
care for all women following a pregnancy
Most pregnant women in the United States are healthy and
experience healthy pregnancy and birth outcomes. For these
women, internatal care is still important because it offers an
opportunity for wellness promotion. In this section, we de-
scribe the core contents of internatal care, including risk as-
sessment, health promotion, clinical interventions, and psy-
chosocial interventions (Table 1). These components should
be offered to every woman following a pregnancy, regard-
less of her risk status. We recommend expanding the current
six-week postpartum visit to three or more internatal visits,
at 2 weeks, 6 weeks, and 6 months postpartum, with an-
nual follow-up beginning at one year postpartum. We will
expand on the rationale for the recommended schedule of
visits, and address issues related to systems integration later
in this section.
Risk assessment
The primary objective of risk assessment is to identify on-
going problems that need to be addressed. Most pregnant
women in the U.S. are healthy and thus should have no major
problems postpartum. However, some medical, behavioral or
psychosocial problems may have been overlooked by their
prenatal care providers. Other problems may develop dur-
ing the internatal period. Providers of internatal care should
pay particular attention to five problems that are now com-
monly missed during prenatal or postpartum care: family
violence, infection/immunization, nutrition, depression and
stress (FINDS).
Family violence
The experience of family violence may be quite common
among pregnant and postpartum women in the U.S. Most
studies of the prevalence of physical abuse during pregnancy
report estimates in the range of 4 to 8 percent, though higher
estimates (around 20%) have been reported in some pop-
ulations [10]. Less is known about the prevalence of vio-
lence after pregnancy, with estimates at 3 months postpartum
ranging from 3.2% in a population-based survey to 21% in
a prospective study of adolescent mothers [11, 12]. In the
latter study [12], three of four women who reported inti-
mate partner violence (IPV) had not reported IPV prior to
delivery. Family violence puts maternal health and child de-
velopment at great risk. The literature contains solid links
between intimate partner violence and child abuse [13]. Be-
cause violence is frequently missed by healthcare providers
including prenatal care providers, we recommend routine
screening for family violence during every internatal visit.
Several brief screening instruments, such as the 4-item Hurt
Insulted Threatened or Screamed at (HITS), the 3-item Part-
ner Violence Screen (PVS), and a 3-item Abuse Assessment
Screen (AAS), can be effectively used to screen for IPV in a
clinical setting [13].
Infection/immunization
Some infections may go unrecognized or untreated during
pregnancy. Chronic, untreated infections, such as periodon-
tal disease, could pose a threat not only to the next preg-
nancy [14], but also to the mother’s long-term health as
well [15]. Most women are not screened for periodontal dis-
ease during prenatal care, and many women lack access to
oral health services following pregnancy. While presently
there is insufficient evidence to justify universal screening
for asymptomatic infections among “low-risk” women in
the internatal period (other than the U.S. Preventive Ser-
vices Task Force (USPSTF) recommendation for Chlamydia
screening in women under the age of 25) [16], in some
populations routine screening for periodontal, sexually-
transmitted and some urogenital tract infections may be
warranted.
Internatal care also offers an important opportunity to up-
date women’s immunization status. The USPSTF and other
national advisory committees recommend that 1) all adults
receive periodic diptheria-tetanus toxoids booster every
10 years, 2) all young adults receive a series of Hepati-
tis B vaccines, 3) all adults born after 1956 who lack evi-
dence of immunity receive vaccination against measles and
mumps, and 4) all women of childbearing age be screened
for rubella and varicella susceptibility; susceptible nonpreg-
nant women of childbaring age should be offered vaccina-
tion and avoid conception for at least 28 days after vacci-
nation; susceptible pregnant women should be vaccinated
immediately after delivery (Table 1). Immunization status
should be assessed and updated at the six-week internatal
visit.
Nutrition
Nutrition can play an important role in promoting mater-
nal health and child development, and yet women’s nutri-
tional needs are often overlooked by prenatal or postpar-
tum care providers. One recent population-based survey in
California found that nearly one in three pregnant women
who were income-eligible for Women, Infants, and Children
(WIC) program reported being food-insecure; of these, one
in four reported not being enrolled in WIC [17]. Nutritional
screening should address the ABCD’s of nutritional risks:
Springer
S110 Matern Child Health J (2006) 10:S107–S122
Table 1. Recommended content and schedule of internatal care, and organizations recommending these practice standards
Risk assessment Organizationsa Scheduleb
Core content of internatal care for all women
Family violence JACHO, AMA 1, 2, 3
Infections
Chlamydia USPSTF, ACPM 2
Periodontal ADA 2
Immunizations
Diptheria-tetanus booster USPTSF, ACPM, HHS 2
Hepatitis B USPTSF, ACPM, HHS 2
Measles and mumps USPTSF, ACPM, HHS, ACIP 2
Rubella USPTSF, ACPM, HHS, ACIP 2
Varicella USPTSF, ACPM, HHS, ACIP 2
Nutrition USPSTF 1,2, 3
Depression USPSTF, ACOG 1, 2, 3
Stress 1, 2, 3
Health promotion
Breastfeeding AAP, HP2010 1, 2, 3
Back-to-Sleep AAP, NICHD, HP2010 2
Exercise NHLBI, HHS, HP2010 2
Exposures
Smoking, alcohol, drug use HHS, ACOG 1, 2, 3
Mercury FDA/EPA 2, 3
Lead CDC, AAP 2, 3
Dioxins IOM 2, 3
Indoor/outdoor pollutants & allergens NHLBI 2, 3
Family planning ACOG/AAP 1, 2, 3
Folate supplementation CDC, AAP 3
Clinical interventions
Height and weight measurements ICSI, ACOG 1, 2, 3
Blood pressure ICSI, ACOG 2
Total skin examination ACS, ACPM 2
Clinical breast examination ACS, ACOG 3
Papanicolau smear and pelvic examination ACS, ACOG 2
Screening mammography ACS, ACOG 3
Psychosocial interventions
Social services 1, 2, 3
Clinical support 1, 2, 3
Parenting support 1, 2, 3
Enhanced content of internatal care for high-risk women
Chronic hypertension
Risk assessment, health promotion, clinical & psychosocial interventions NHLBI
Gestational hypertension
Risk assessment, health promotion, clinical & psychosocial interventions NHLBI, ACOG
Pregestational diabetes
Risk assessment, health promotion, clinical & psychosocial interventions ADA
Gestatational diabetes
Risk assessment, health promotion, clinical & psychosocial interventions ADA, ACOG
Overweight/obesity
Risk assessment, health promotion, clinical & psychosocial interventions NHLBI, HHS USPSTF
Preterm birth
Risk assessment
Reproductive history ACOG
Family history ACOG
Medical assessment ACOG
Nutritional assessment ACOG
Social assessment ACOG
Springer
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Table 1. Continued
Risk assessment Organizationsa Scheduleb
Health Promotion
Smoking cessation HHS
Substance abuse treatment ACOG
Optimal prepregnancy BMI IOM
Ensure adequate omega-3 fatty acids intake ISSFAL, IOM
Family planning ACOG/AAP
Clinical interventions
Progesterone use in subsequent pregnancy ACOG
Psychosocial Interventions
Services for children with special health care needs AAP
Home visitation AAP
aReferences to these recommendations available through the authors. Abbreviations: JACHO, Joint Commission on Accreditation of Healthcare
Organizations; AMA, American Medical Association; USPSTF, United States Preventive Services Task Force; ACPM, American College of
Preventive Medicine; ADA, American Dental Association; HHS, Department of Health and Human Services; ACIP, Advisory Committee on
Immunization Practices (CDC). ACOG, American College of Obstetricians and Gynecologists; AAP, American Academy of Pediatrics; HP2010,
Healthy People 2010; FDA, Food and Drug Administration; EPA, Environmental Protection Agency; CDC, Centers for Disease Control and
Prevention; IOM, Institute of Medicine; NHLBI, National Heart, Lungs, and Blood Institute; ICSI, Institute for Clinical Systems Improvement;
ACS, American Cancer Society; ADA, American Diabetes Association.
bRecommended schedule for each component of core content of internatal care; 1 = 2-week visit, 2 = 6-week visit; 3 = 6-month visit . Schedule
for enhanced content varies according to need
anthropometric (e.g. low or high body mass index), bio-
chemical (e.g. for anemia or folate deficiency in some popu-
lations), clinical (e.g. eating disorder) and dietary (e.g. con-
tent, pattern, food insecurity). An abbreviated 6-item version
of the Household Food Security Scale can be used to screen
for food insecurity. Inquiry should be made about folate or
multivitamin supplementation (see under Health Promotion).
We recommend routine screening of nutritional risks at every
internatal visit.
Depression
Maternal depression affects a large number of women and
their children. A recent systematic review reported com-
bined estimates of the point prevalence of major and minor
depression ranging from 8.5 to 11 percent during pregnancy,
and 6.5 to nearly 13 percent during the first year postpar-
tum [18]. Maternal depression can have negative long-term
impact on both maternal health and child development, but
is often missed by prenatal and postpartum care providers.
We recommend routine screening for maternal depression at
every internatal visit. Fairly accurate and feasible screening
measures are available, including the Postpartum Depression
Screening Scale (PDSS), Edinburgh Postnatal Depression
Scale (EPDS), Beck Depression Inventory (BDI), and the
Center for Epidemiologic Studies Depression Scale (CES-
D) [18]. The evidence available, albeit limited, suggests that
providing some form of psychosocial support to pregnant
and postpartum women at risk of having a depressive illness
may decrease depressive symptoms [18].
Stress
Maternal stress is perhaps the hardest to screen; clinicians are
often at a loss as to how to screen or what to do with a positive
screen. Yet chronic stress can pose significant risks to ma-
ternal health and child development. For the mother, chronic
stress can cause wear and tear to her body’s adaptive systems,
what McEwen refers to as allostatic load, which could lead to
more rapid deterioration in her health and function over time
[19]. For the infant (or the fetus in a subsequent pregnancy),
maternal stress could result in the re-programming of the
child’s basic autonomic rheostat and alteration of immune
regulation, leading to increased vulnerability to disease and
dysfunction later in life [20]. There is an important need
for the development of a multi-dimensional screening tool
for stress that can be feasibly implemented in a clinical set-
ting. For now, clinicians need to ask about major stressors
in women’s lives (e.g. homelessness, unemployment, family
violence, social isolation) at every internatal visit, and find
resources and supports to help the family deal with these
stressors.
Thus even for healthy mothers with healthy infants, much
can be done to reduce health risks and promote well-being
during internatal care. In addition to the five areas we high-
lighted (FINDS–family violence, infections/immunization,
nutrition, depression, and stress), a battery of reproductive,
medical, family, genetic and psychosocial risks should be
routinely assessed during internatal care. Other areas of risk
assessment can be added to the contents of internatal care as
the model becomes more fully developed.
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A word of caution about risk screening
Presently a major limitation on the effectiveness of risk
screening is the lack of available or accessible services for
those with a positive screen. The benefit of depression screen-
ing is limited when there are no mental health services avail-
able or accessible to refer mothers who screen positive for
depression. And a lack of support services (and coordination
thereof) for abuse victims is identified by many providers
as a major deterrent to screening for family violence. For
risk screening to be effective, it needs to be followed up
by effective interventions. This means having all the neces-
sary resources and service capacity (e.g. oral health services
for those with periodontal disease, nutritional support for
those who are food-insecure, housing assistance for home-
less mothers and families) to assist those with a positive
screen.
Health promotion
The primary objective of health promotion is to promote the
health and wellbeing of the mother, infant, and family. We
will highlight six components health promotion during inter-
natal care: breastfeeding, back-to-sleep, exercise, exposures,
family planning and folic acid (BBEEFF).
Breastfeeding
Despite well-known benefits of breastfeeding for both
mother and infant [21], at least one-third of mothers in the
U.S. never initiate breastfeeding [22]. Among women who
initiated, nearly one in five will stop nursing by one month,
and nearly two-thirds will stop by six months [22], despite
current recommendation to breastfeed for at least one full
year [21]. Internatal care offers an important opportunity
to promote breastfeeding, particularly the initial two-week
visit to address nascent problems, the six-week visit to an-
ticipate problems related to transition back to work, and the
six-month visit to encourage continued breastfeeding with
introduction of solid foods.
Back-to-sleep
With the introduction of the Back-to-Sleep campaign by the
American Academy of Pediatrics in 1992, the overall inci-
dence of sudden infant death syndrome (SIDS) has decreased
by almost 50% [23]. Despite this success, SIDS continues
to be a leading cause of infant death in the U.S., as well
as racial disparity in infant mortality [23]. SIDS rate among
black infants remains more than twice that of white infants,
even after the implementation of the Back-to-Sleep cam-
paign [23]. Black infants are more likely than white infants
to be placed in the prone position and soft sleep surfaces
for sleep [23]. Providers of internatal care need to discuss
the infant’s sleep environment with the parents. Because the
risk of SIDS peaks at 2 to 4 months of age, the six-week
visit offers an important opportunity to talk about back-to-
sleep.
Exercise
Health education about physical activities should be part of
an on-going effort for wellness promotion during internatal
care. The 1988 National Maternal and Infant Health Survey
revealed that 25 percent of white women and 45 percent of
black women were heavier by 4.1 kg (nearly 9 pounds) or
more at 10 to 18 months post partum than they were before
pregnancy [24]. Clinicians can help women develop a weight
loss program that consists of healthy dieting, physical activ-
ities, and behavioral modifications if needed. The National
Heart, Lung, and Blood Institute recommends that all adults
should set a long-term goal to accumulate at least 30 min
or more of moderate-intensity physical activity on most, and
preferably all, days of the week [25]. For women in the
postpartum period, prepregnancy exercise routines may be
resumed gradually as soon as it is physically and medically
safe. Clinicians need to routinely discuss physical activity
with the woman, particularly at the six-week and six-month
visits.
Exposures
Cigarette smoking poses a significant threat to the health of
the mother, her infant, and her subsequent pregnancy. Ap-
proximately one in eight (11.2%) U.S. women who gave birth
in 2002 reported smoking cigarettes during pregnancy [26].
Furthermore, up to 70% of women who quit smoking during
pregnancy will relapse within 6 months of delivery [27]. Ef-
fective models of clinical intervention for smoking cessation
(e.g. 5A’s) and relapse prevention have been developed and
should be incorporated into internatal care [28]. Prenatal ex-
posure to alcohol and other substances like cocaine and am-
phetamines have been associated with birth defects as well as
adverse pregnancy and neurodevelopmental outcomes. Ac-
cording to the Behavioral Risk Factor Surveillance System,
in 1999 the prevalence of any alcohol use and binge drinking
among pregnant women in the U.S. was 12.8 and 2.7%, re-
spectively [29]. Postpartum use and recidivism rates are less
well described. Several screening questionnaires have been
developed to detect problem drinking which may also prove
helpful in detecting substance abuse, include T-ACE (toler-
ance, annoyed, cut down, eye opener) questions, the CAGE
(cut-down, annoyed, guilty, eye-opener) questionnaire, and
the brief MAST questionnaire [30]. All women should be
screened at the time of their first internatal visit, and referral
for evaluation and treatment should be offered to those who
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screen positive. Additionally, mothers whose infants are at
risk for neurobehavioral problems from prenatal exposures
should be provided resources for early developmental eval-
uation and interventions for their infants [30].
A large number of environmental exposures during the
internatal period can affect maternal health and child de-
velopment. For example, chronic exposures to indoor and
outdoor pollutants and allergens, including household molds
and dust mites, may increase the child’s future risk for atopy,
allergies, and asthma. Less is known about the long-term
effects of such exposures to maternal health and subsequent
pregnancy outcomes. Lead is a potent developmental neu-
rotoxicant and immunotoxicant, and household exposures
can come from old paint, leaching from plumbing, and ce-
ramic dinnerware and glazes. Certain measures can be taken
to reduce household exposures to pollutants, allergens and
lead. Exposure to mercury can be reduced by adherence to
the EPA/FDA joint advisory related to consumption of fish
and shellfish, and exposure to dioxins can be reduced by de-
creasing dietary fat consumption (Table 1). Clinicians need
to assess and discuss with their patients avoidance of ex-
posures that could adversely impact on maternal health and
child development at every internatal visit, but particularly
at the 6-week and 6-month visits.
Family planning
Family planning is vital to the health and wellbeing of women
and their families [31]. Unintended pregnancy and short in-
terpregnancy intervals are associated with increased risk for
adverse birth outcomes [31, 32]; family planning can reduce
the risk by promoting effective contraceptive use and opti-
mal birth spacing. An unintended pregnancy also puts future
maternal health and social wellbeing at risk; family planning
can protect maternal health and choice [31]. Discussion of
family planning should begin prenatally and prior to dis-
charge from the hospital; it should be addressed again at
the two-week and six-week internatal visits, including risks,
benefits and side effects of available contraceptive options
and plans for future childbearing. Adherence to method and
side effects should be reassessed at the six-month visit.
Folate supplementation
Folate is important to both maternal and child health. Mater-
nal folate deficiency has been linked to future risk for cardio-
vascular and other chronic adult diseases, as well as neural
tube and other birth defects in the offspring. Periconcep-
tional (preconceptional and in early pregnancy) use of folic
acid has been demonstrated to reduce the occurrence and
recurrence of neural tube defects [33]. Thus the U.S. Public
Health Services recommends that all women of childbear-
ing age consume 400 micrograms of folic acid daily [34].
Even though there are several ways of getting this amount of
folic acid everyday, two-thirds of U.S. women of childbear-
ing age still do not consume enough folic acid, and surveys
continue to find substantial knowledge gaps regarding the
benefits of folic acid. Folic acid should be promoted at ev-
ery internatal visit, or at the minimum during the six-month
visit. We feel that the recommendation for folic acid can
be broadened to include daily multivitamin supplementation
given the potential benefits of a number of other vitamins
(e.g. B12) and elements to maternal health and subsequent
pregnancy outcomes, particularly for women with nutritional
deficiencies.
Table 1 summarizes the core contents of health promotion
during internatal care, with an emphasis on BBEEFF (breast-
feeding, back-to-sleep, exercise, exposures, family planning
and folic acid). Other topics can be added to health pro-
motion as the model of internatal care becomes more fully
developed.
Clinical interventions
Most women in this category are, by definition, healthy and
require little in the way of clinical interventions during in-
ternatal care, other than the standard preventive health ser-
vices recommended for all women of childbearing age (Table
1). These include periodic height, weight and blood pres-
sure measurements, total skin examination, clinical breast
examination, Pap smear and bimanual pelvic examination
every 1 to 3 years. Mammography should also be performed
in women ages 40 and above. We will address clinical in-
terventions for women with chronic conditions in the next
section.
Psychosocial interventions
Many healthy women who gave birth to a healthy infant will
nonetheless need some psychosocial support. There are three
types of social support that need to be made available as part
of the core package of internatal care services: 1) social ser-
vices, 2) clinical support, and 3) parenting support (Table 1).
Social services may include assistance with obtaining certain
public insurance (e.g. SCHIP) or benefits (e.g. TANF, EITC).
Some women may not be aware of their eligibility for child
care subsidies (e.g. CCDF) or availability of early childhood
education programs. Women experiencing intimate partner
violence may need multiple medical, legal, and social ser-
vices and could use some help with service coordination.
The internatal visits provide a platform for accessing these
social services.
Women who experience postpartum depression or other
affective disorders may benefit from some forms of psy-
chological support and therapy during the internatal period.
Couples who experience problems with marital or sexual
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relationship in the internatal period may benefit from coun-
seling or interventions. Women with alcohol or drug prob-
lems could also use clinical support and treatment. These and
other professional clinical support services should be made
available and accessible as part of standard internatal care
services.
Many parents could benefit from some parenting support,
such as mother support groups or parenting classes. A current
innovative idea in prenatal care is “centering” in pregnancy,
which provides social support to pregnant women through
group prenatal care [35]. While this idea remains to be tested,
we believe that group internatal care–a “centering” in inter-
natal care model–may provide additional support for some
women, particularly around issues related to parenting prac-
tices and the stress of parenting.
A note on psychosocial interventions
Throughout this paper, the readers will notice an imbalance
in the levels of details we used to describe clinical and psy-
chosocial interventions. That is, clinical recommendations
are, for the most part, described with much greater speci-
ficity than psychosocial interventions. It is certainly not our
intention to propose a predominantly biomedical model of
internatal care. Rather, the lack of specificity in our descrip-
tion of psychosocial interventions reflect both the complexity
of psychosocial issues that families–particularly low-income
families–face for which there are often no easy solutions,
as well as the dearth of well-designed and evaluated inter-
vention programs addressing these psychosocial issues. For
example, mental health services alone are unlikely to be ef-
fective in treating the postpartum depression of a homeless
mother, and housing assistance alone is unlikely to find her
stable housing without sustainable income and employment,
but few well-designed intervention studies have critically
evaluated the impact of a comprehensive package of men-
tal health services, housing assistance, work- and life-skills
training and childcare on maternal and family health. Our
model of internatal care is unlikely to be effective without
effective psychosocial interventions, but we will not know
what these are as long as we keep looking for quick biomed-
ical fixes. Future intervention studies on internatal care need
to take a more integrative, comprehensive approach to im-
proving family and women’s health.
Service coordination and integration
As aforementioned, presently some referral services (e.g.
mental health services, oral health services) are unavailable
or inaccessible to many women between pregnancies. But
even if the services are available, they are often poorly coor-
dinated. Fragmentation in service delivery can deter access
to care, particularly for low-income women with many other
competing needs. Providers of internatal care need to con-
sider how to better coordinate and integrate services in order
to improve access. This can be accomplished by establishing
a well-developed referral network. In some populations, care
coordination or case management provided by a nurse or so-
cial worker may be needed. Ideally these services should be
provided at one location to increase service coordination and
integration. For example, the two-week internatal visit can
be provided at the same time and location as the two-week
well-baby check-up, with on-site WIC, health education, and
social services that allow for “one-stop shopping.” We will
take up issues related to the organization and delivery of
internatal care that will maximize access and utilization of
services in a series of papers to follow.
Schedule of visits
In developing a schedule of visits for internatal care, we
had to first wrestle with two questions. First, shouldn’t the
schedule of visits be individualized according to individ-
ual needs? While we support this view, we nonetheless feel
that it may be useful to recommend some minimum stan-
dards to start a dialogue about this topic. For healthy women
with healthy infants, we propose expanding the current six-
week postpartum visit to three or more internatal visits, at
2 weeks, 6 weeks, and 6 months postpartum, with annual ex-
ams beginning at one year postpartum. For some activities,
the six-week postpartum visit may be too little too late. For
example, one in five mothers who initiated breastfeeding will
quit nursing within the first month [22]; a 2-week postpartum
visit may offer more timely encouragement and interventions
for maintenance of breastfeeding than a 6-week visit could.
The 2-week visit also offers an opportunity to follow-up on
wound care for cesarean delivery. Whenever possible, this
visit should be coordinated with the two-week well-baby
check-up, preferably at the same location, to increase mo-
tivation for attendance. We feel that it is important to keep
the current six-week postpartum visit as the second inter-
natal visit. This is a well-established visit in obstetrics, with
well-defined contents. This visit, however, can be made more
useful by expanding its contents. We feel that a third interna-
tal visit at 6 months is important for follow-up on a number
of issues, such as breastfeeding and family planning. The
standard annual visits should begin at one year postpartum
(Table 1).
Second, shouldn’t any routine visit by a woman who
may, at some time, become pregnant again be viewed as an
opportunity to emphasize the importance of internatal health
and habits [36]? While we support this view, we nonetheless
feel that it would be preferable to recommend a schedule
of internatal visits rather than relying on “any routine visit.”
Several components of internatal care are time sensitive
(e.g. counseling about breastfeeding and family planning at
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2 weeks or about SIDS at 6 weeks) which should not wait
for any routine visit. Scheduled internatal visits may be
particularly important for women who are not making rou-
tine visits, or who are seeking care through the emergency
department or urgent care clinics which lack the resources
and capacity to provide comprehensive internatal care. We
would also like to see internatal care become reimbursable
visits, with standardized contents and schedule (rather than
as an add-on to a visit for mastitis or cystitis), which may
increase provider incentives to provide internatal care. Issues
related to patient motivation and provider reimbursement
will be addressed in a series of papers to follow.
Recommended contents of enhanced internatal care
for high-risk women
In this section, we begin to define the contents of enhanced
internatal care for high-risk women (Table 1). We focus on
four groups of high-risk women: 1) women with chronic
hypertension or history of hypertensive disorders during
pregnancy, 2) women with pregestaional or gestational dia-
betes mellitus, 3) women who are underweight, overweight
or obese, and 4) women with prior preterm birth. We call
attention to the first 3 groups because they are often under-
served in the internatal period, especially if they gave birth
to a healthy infant. Their continued health needs may not be
met because they had a good birth outcome. Some women
will lose healthcare coverage (e.g. pregnancy-related Medi-
caid), and will have little on-going care despite their chronic
conditions. We call attention to the 4th group because of
their high recurrence risk [8] and the significance of recur-
rence. The goals of internatal care for these women are to
provide ongoing care for their health problems and optimize
their health prior to next pregnancy. In addition to the core
contents of universal internatal care recommended above for
all women of childbearing ages, we will examine what en-
hanced contents may benefit their long-term health, as well
as the outcome of their subsequent pregnancy.
Women with chronic hypertension or hypertensive
disorders during pregnancy
Hypertensive disorders are the most frequently reported med-
ical risk factor during pregnancy [11]. Among the 4 mil-
lion U.S. women who gave a live birth in 2002, more than
150,000 had “pregnancy-associated” (gestational) hyperten-
sion, more than 3,000 had chronic hypertension, and nearly
13,000 had eclampsia [11].
Among women with chronic hypertension (i.e. hyperten-
sion diagnosed prior to twentieth week of gestation and
probably antedates the pregnancy) that persists after preg-
nancy, guidelines for evaluation and treatment are well es-
tablished and can be incorporated into the contents of inter-
natal care [37]. Risk assessment has three major objectives:
1) to assess lifestyle and identify other cardiovascular risk
factors or concomitant disorders that may affect prognosis
and guide treatment 2) to reveal identifiable causes of hyper-
tension, and 3) to assess the presence or absence of target
organ damage and cardiovascular disease. Initial evaluation
should include medical history, physical examination (in-
cluding fundoscopic and cardiovascular examinations), lab-
oratory testing and other diagnostic procedures (including an
electrocardiogram and testing for renal function and lipopro-
tein profile). Health promotion should promote weight re-
duction, DASH (Dietary Approaches to Stop Hypertension)
eating plan, dietary sodium reduction, physical activities,
moderation of alcohol, and smoking cessation. Clinical in-
terventions should include drug therapy for all women with
hypertension, as well as prehypertensive women with com-
pelling indications (e.g. chronic kidney disease or diabetes).
Follow-up should be monthly until the blood pressure goal
is achieved, and then at 3–6 months interval thereafter dur-
ing the internatal period. Psychosocial interventions should
address chronic stressors that may exacerbate the chronic hy-
pertension, as well as barriers (e.g. financial, motivational)
to adherence with treatment protocol.
The contents of internatal care for women with ges-
tational hypertension, pre-eclampsia, and eclampsia are
less well defined, especially if the hypertension does not
persist following pregnancy. In most women with gesta-
tional hypertension, the blood pressure will become nor-
mal during the first week postpartum; for women with
preeclampsia the hypertension will take longer to resolve.
If the hypertension has not remitted by the 6-week visit,
the women should be reexamined 6 weeks later, when per-
sisting pathology will probably be chronic [38]. During in-
ternatal care, providers need to discuss with their patients
recurrence risk in the subsequent pregnancy. They also need
to be aware that preeclampsia has been associated with in-
creased risk of maternal cardiovascular diseases later in life
[39], and that attention to cardiovascular risk factors is re-
quired in all subsequent internatal care and wellness visits.
Presently there is no proven internatal clinical intervention
for the prevention of recurrent gestational hypertension or
preeclampsia.
During a subsequent pregnancy, antihypertensive therapy
should be used only for pregnant women with severe hyper-
tension, as pharmocologic treatment of women with uncom-
plicated mild chronic hypertension has not been found to be
beneficial [38]. Several studies failed to demonstrate a ben-
efit for low-dose aspirin in preventing preeclampsia among
women with chronic hypertension [38]. When chronic hy-
pertension is complicated by intrauterine growth restriction
or preeclampsia, fetal surveillance is warranted. For women
with preeclampsia during a previous pregnancy, low-dose
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aspirin started in the second trimester of pregnancy did not
reduce the recurrence risk of preeclampsia [38]. Further stud-
ies are needed to identify effective interventions during the
internatal period and subsequent pregnancy to prevent recur-
rent gestational hypertension or preeclampsia.
Women with pre-gestational or gestational
diabetes mellitus
Diabetes complicating pregnancy is the second most fre-
quently reported medical risk factor during pregnancy [11].
In 2002, more than 130,000 women reported having diabetes
during pregnancy [11]. For women with pre-gestational di-
abetes, they are at increased risk for microvascular, neuro-
pathic and cardiovascular diseases, especially if the diabetes
is long-standing and poorly controlled. Their risks are re-
duced with tight glycemic control. Additionally, their fetuses
are at increased risk for stillbirth and congenital anoma-
lies. Preconception glycemic control among women with
pre-gestational diabetes has been shown to reduce the risk
of congenital anomalies [40]. Women who had gestational
diabetes have 30–70% chance of recurrence during their
next pregnancy [41] and an increased risk of developing
Type II diabetes later in life [42]. Gestational diabetes in-
creases the risk of fetal macrosomia, birth trauma, newborn
hypoglycemia and hyperbilirubinemia. Evidence from ani-
mal models suggests that gestational diabetes, especially if
poorly controlled, may also program insulin and leptin re-
sistance in the fetus, leading the greater susceptibility for
diabetes and obesity in the offspring [43].
For women with pre-gestational diabetes, internatal care
should follow the guidelines issued by the American Di-
abetes Association on preconception care of women with
chronic diabetes [44]. At the initial office visit, risk assess-
ment should include a complete history, physical exami-
nation (including cardiovascular, neurological, and dilated
retinal exams), and laboratory evaluation (including glyco-
sylated hemoglobin (HbA1c), serum creatinine and 24-h uri-
nary excretion of total protein and/or albumin, and measure-
ment of thyroid stimulating hormone and/or free thyroxine
level in women with type 1 diabetes because of the 5 to 10%
coincidence of hyper- or hypothyroidism) and electrocar-
diogram if the diabetes has been long-standing. Health pro-
motion should emphasize practical self-management skills
essential for glycemic control and preparation for preg-
nancy including the use of an appropriate meal plan, self-
monitoring of blood glucose (SMBG), self-administration of
insulin and self-adjustment of insulin doses, treatment of hy-
poglycemia (patient and family members), incorporation of
physical activity, and development of stress reduction tech-
niques. Patients should be counseled about fetal and neonatal
complications (and possibly long-term health consequences)
of maternal diabetes, including the risk of congenital malfor-
mations, and the need for effective contraception and optimal
glycemic control prior to the next pregnancy. Clinical inter-
ventions include dietary control and pharmacological treat-
ment using oral hypoglycemics or insulin. Glycemic control
can be self-monitored at home, and glycosylated hemoglobin
levels should be evaluated at 1- to 2-month intervals until
stable. Follow-up visits should be at 1- to 2-month intervals,
and frequent phone contact for adjustment of insulin doses
and other aspects of the treatment regimen is advised. Psy-
chosocial interventions should address barriers to adherence
with treatment protocol. Referral to and coordination with a
dietician and programs such as W.I.C. or Sweet Success in
California may enhance treatment efficacy. Stress manage-
ment should be emphasized because stress can affect dietary
control as well as glucose homeostasis.
For women with gestational diabetes in a previous preg-
nancy, guidelines for internatal care are less well estab-
lished. The American Diabetes Association recommends that
a 75-g oral glucose tolerance test (GTT) be performed 6 to
8 weeks after delivery [41]. The extent to which this rec-
ommendation is adhered is presently unknown. We believe
that much more can be done in the internatal period to pro-
mote maternal health (as well as fetal health in a subse-
quent pregnancy) among women with gestational diabetes.
Because these women are at increased risk for developing
type II diabetes, risk assessment should include a fasting
glucose once a year. If clinical assessment suggests polycys-
tic ovarian syndrome and/or metabolic syndrome, periodic
testing for lipoprotein profiles, fasting glucose, and possi-
bly glucose tolerance test may be warranted [45]. Patients
should be evaluated for glucose intolerance before their next
pregnancy. For health promotion, all women who have had
gestational diabetes should be encouraged to exercise and
lose weight if they are obese. Dietary counseling is recom-
mended given their increased risk for future type II diabetes.
Presently there are no specific clinical interventions recom-
mended in the internatal period for women with a history of
gestational diabetes.
During a subsequent pregnancy, women with pregesta-
tional diabetes using oral hypoglycemic agents should be
switched to insulin because the safety and efficacy of cur-
rently available oral hypoglycemics have not been evalu-
ated for use in pregnancy among women with pregesta-
tional diabetes. For women with gestational diabetes in a
prior pregnancy, the use of a second-generation oral hy-
poglycemic agent (i.e. glibenclamide or glyburide) may
be considered if gestational diabetes recurs in a subse-
quent pregnancy. The agent does not cross the placenta
and has been shown to be comparable to insulin in im-
proving glucose control for women with gestational dia-
betes [46]. Weight gain during pregnancy should be closely
monitored.
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Women who are underweight, overweight, or obese
A growing number of women of reproductive age in the U.S.
are overweight or obese. According to the 1997 National
Health Interview Survey, one-third of women ages 18 to 24
and 43% of women ages 25 to 44 are overweight [47]. The
survey also found one in eight women ages 18 to 24 and
one in six women ages 25 to 44 are obese [47]. Based on the
CDC 2003 Pregnancy Nutrition Surveillance System (PNSS)
of nearly 728,000 low-income pregnant women, 43% had
a prepregnancy body mass index (BMI) that is considered
overweight or obese, up from less than 30% in 1989 [48].
Maternal obesity poses a threat to not only subsequent preg-
nancy outcomes, but also long-term maternal health. Preg-
nancy itself is a risk factor for maternal obesity. According
to the 2003 PNSS, more than 44% had gained more than the
ideal weight gain [48] and, as previously cited [24], weight
retention following pregnancy is common. Weight retention
needs to be addressed during internatal care, particularly for
women who are overweight or obese.
According to the 2003 PNSS, one in eight pregnant
women were underweight before pregnancy, and one in four
had gained less than the ideal weight gain during preg-
nancy [48]. Both low pre-pregnancy BMI and poor preg-
nancy weight gain have been shown to be risk factors for
preterm delivery and low birth weight [49].
For women who are underweight, overweight, or obese,
an important goal of internatal care is to optimize their weight
prior to the next pregnancy. For risk assessment, the BMI can
be used because it provides an acceptable approximation of
body fat and fair correlation with disease outcomes. Poten-
tial causes of underweight (e.g. eating disorders, food inse-
curity), overweight or obesity (e.g. polycystic ovarian syn-
drome) need to be evaluated. For health promotion, women
who are underweight should be encouraged to gain weight
through healthy nutrition; for women who are overweight
or obese, clinical guidelines have been established for the
identification, evaluation, and treatment of overweight and
obesity [50]. These guidelines should be followed for inter-
natal care. The initial goal of weight loss therapy should be
to reduce body weight by approximately 10 percent from
baseline, and weight loss should be about 1 to 2 pounds per
week for a period of about 6 months. This amount of post-
partum weight loss in overweight women does not appear
to affect the growth of their infants, even if they are exclu-
sively breastfed [51]. Weight loss and weight maintenance
therapy should employ the combination of low-calorie diets,
increased physical activity, and behavior therapy. Clinical
interventions may include weight loss drugs as an adjunct to
diet and physical activity for patients with a BMI of ≥ 30,
as well as for patients with a BMI of ≥ 27 with concomi-
tant risk factors or diseases. After successful weight loss,
the likelihood of weight loss maintenance is enhanced by a
program consisting of dietary therapy, physical activity, and
behavior therapy which should be continued until the next
pregnancy. Psychosocial interventions should address bar-
riers to healthy nutrition and coordination with a dietician,
WIC and other community programs. The schedule of inter-
natal visits should be individualized; the literature suggests
that frequent contacts between professional counselors and
patients help promote healthy weight maintenance. In a sub-
sequent pregnancy, the Institute of Medicine guidelines for
weight gain during pregnancy should be promoted based on
prepregnancy BMI [52].
Women who had a prior preterm birth
Presently this group of women is most often targeted for
internatal care. Preterm birth is a leading cause of infant
mortality and long-term disabilities in children in the U.S..
Prior preterm birth is the strongest and most consistent pre-
dictor of a subsequent preterm birth. This may be due to the
fact that many of the biobehavioral risk factors for preterm
birth are carried from one pregnancy to the next. The goal of
internatal care for these women is to prevent recurrence of
preterm birth by addressing these continuing biobehavioral
risks prior to their next pregnancy.
Risk assessment
Women who had a preterm birth should undergo a com-
prehensive risk assessment, starting with a complete re-
view of their obstetrical history at the two-week visit. Dis-
tinction should be made between spontaneous and induced
preterm deliveries. Details about the preterm delivery should
be obtained. Work-up should be guided by known etio-
logic pathways (e.g. infectious-inflammatory, vascular, neu-
roendocrine and pathologic uterine over-distension) [53].
To identify infectious-inflammatory causes, medical records
should be reviewed for untreated infections (e.g. asymp-
tomatic bacteriuria), physical examination should be per-
formed to uncover on-going, chronic infections (e.g. pe-
riodontal or reproductive tract infections), and placental
pathology should be reviewed for evidence of chorioam-
nionitis [54]. To identify vascular causes, placental pathology
should be reviewed for evidence of uteroplacental ischemia
and thromboses [54]. The presence of these findings, in the
absence of known causes, may indicate work-up for hered-
itary or acquired thrombophilia [55]. To identify neuroen-
docrine causes, inquiries should be made about psychoso-
cial stress and support during pregnancy. Special attention
should be paid to FINDS (family violence, infections, nutri-
tion, depression, and stress), since these risk factors may be
involved in one or more etiologic pathways leading to the oc-
currence or recurrence of preterm birth. Review of past medi-
cal history should focus on conditions that could increase the
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risk of preterm deliveries (e.g. systemic lupus erythematosus
or renal disease). Review of family history should identify
other preterm deliveries in the family (particularly among
first-degree relatives), as well as other conditions associated
with preterm deliveries. A thorough review of reproductive
history, including other preterm births or pregnancy losses,
sexual history including sexually transmitted infections, past
and current contraceptive use, and plans for future childbear-
ing and child spacing should be conducted.
Health promotion
The goal of health promotion is to promote protective fac-
tors and reduce risk factors for recurrent preterm births. We
will highlight three areas of health promotion: smoking ces-
sation, healthy nutrition, and family planning. First, expo-
sure to cigarette smoking significantly increases the risk of
preterm delivery. Smoking cessation (by women and their
partners) should be encouraged during internatal care. As
previously discussed, effective models of clinical interven-
tions (e.g. 5A’s) have been developed [28]. Second, healthy
nutrition should be promoted. Low pre-pregnancy BMI has
been associated with increased risk for spontaneous preterm
birth, while high pre-pregnancy BMI has been associated
with increased risk for indicated preterm birth [49]. For
women with a history of preterm birth, achieving a healthy
weight prior to their next pregnancy may reduce the risk of
recurrent preterm birth. A number of programs have demon-
strated effectiveness in helping women achieve and maintain
healthy weight [56]. Additionally, nutrition may also play an
important role in modulating several of the etiologic path-
ways leading to preterm birth. For example, increased dietary
intake of omega-3 polyunsaturated fatty acids may help mod-
ulate inflammation [57]. Women should be encouraged to
increase consumption of foods rich in omega-3 (the Interna-
tional Society for the Study of Fatty Acids and Lipids rec-
ommends that during pregnancy and lactation women must
ensure a minimum daily intake of 300 mg of Docosahex-
aenoic Acid or DHA, an important source of omega-3 fatty
acids [58]), and decrease consumption of foods high in satu-
rated fatty acids, trans-fats, and partially-hydrogenated oils.
Increasing dietary intake of fruits and vegetables rich in anti-
oxidants and certain phytochemicals should also be encour-
aged. These recommendations could arguably be adopted on
the basis of promoting women’s health alone, even in the
absence of data supporting their effectiveness in prevent-
ing recurrent preterm birth. Third, the importance of family
planning cannot be over-emphasized, particularly for women
with a history of preterm birth. Both unintended pregnancies
and short interpregnancy intervals are associated with in-
creased risk for preterm delivery. Family planning has been
shown to reduce unintended pregnancies and promote op-
timal child spacing. Other BBEEFF topics, such as breast-
feeding and back-to-sleep, are also important to address with
mothers of preterm babies.
Clinical interventions
To our knowledge, there has been only one randomized con-
trolled trial for the prevention of recurrent preterm birth in
which a specific clinical intervention is initiated during the
interpregnancy period [59]. In that study, women with a prior
spontaneous preterm birth at less than 34 weeks of gesta-
tion were randomized at 3 months postpartum to a course
of oral azithromycin and sustained-release metronidazole or
placebo. The regimen was repeated every 4 months until
conception of another pregnancy. The investigators found no
significant difference in the rates of preterm birth between
the study and control groups. In fact, women in the treatment
group, on average, had lower birth weight babies and deliv-
ered 2.4 weeks earlier [59]. In the absence of evidence of ef-
fectiveness for preventing recurrent preterm birth, presently
no specific clinical intervention can be recommended for
women with prior preterm birth in the interpregnancy
period.
Several studies have examined the effectiveness of clini-
cal interventions applied to women with prior preterm birth
during a subsequent pregnancy for the prevention of recur-
rent preterm birth. Perhaps the most promising is the use
of progesterone. A large randomized controlled trial in the
U.S. [60] and two recent meta-analyses [61, 62] found ev-
idence of effectiveness of progestational agents (e.g. 17-
hydroxyprogesterone caproate) for the prevention of preterm
or recurrent preterm birth. However, “because unresolved
issues remain, such as optimal route of drug delivery and
long-term safety of the drug,” the American College of Ob-
stetricians and Gynecologists (ACOG) has issued a commit-
tee opinion that “when progesterone is used, it is important
to restrict its use only to women with a documented history
of a previous spontaneous birth at less than 37 weeks of
gestation” [63]. Another promising clinical intervention is
the use of fish oil supplementation for the prevention of re-
current preterm birth. In the Fish Oil Trials in Pregnancy
(FOTIP) study, fish oil supplementation in a subsequent
pregnancy significantly reduced recurrence risk of preterm
delivery [64]. There is also emerging evidence that scal-
ing and root planing in pregnant women with periodontitis
may reduce preterm birth [65], though no published studies
have evaluated the effectiveness of periodontal screening in
women with prior preterm birth. Further studies are needed
to demonstrate the effectiveness of these interventions.
Perhaps the most controversial clinical intervention is an-
tibiotic treatment of asymptomatic bacterial vaginosis among
women with a history of preterm birth [66, 67]. While
some studies have shown a benefit, others have not. Effi-
cacy of treatment may depend on the agent used, the route of
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administration, the timing of treatment, test of cure, and a
number of host factors. In at least four antibiotic trials in
pregnancy involving women with prior preterm birth [59,
65, 68, 69], antibiotic treatment (of bacterial vaginosis, Tri-
chomonas vaginalis, or periodontal infection) was associ-
ated with higher, not lower, incidence of recurrent preterm
birth. Clearly there is a need for further intervention stud-
ies, guided by better understanding of pharmacokinetics and
pharmacogenetics, disease mechanisms and host response,
as this remains a potentially important area of intervention
for the prevention of recurrent preterm birth.
Psychosocial interventions
A growing body of evidence suggests that maternal psy-
chosocial stress is an important risk factor for preterm deliv-
ery, and that risk can be mitigated by reducing stress and/or
increasing support. However, most extant studies of social
support during pregnancy suffer from methodological flaws
[70], and there is a paucity of research on the effectiveness of
preconception or internatal support. The provision of social,
clinical and parenting support during the internatal period,
as previously described, may be quite valuable to mothers
of a preterm infant, who often has special healthcare and
other developmental needs that require additional support
services. Such services may also be particularly beneficial
to low-SES mothers, who may face greater burdens with
less personal and social resources to deal with them. More
research is needed to identify effective models of interna-
tal psychosocial interventions for women with a history of
preterm delivery.
Service coordination and integration
Women who have had a preterm birth may require multi-
ple services during the internatal period, particularly if their
children have significant disabilities and special healthcare
needs. Providing integrated services, including linkages to
early intervention or other early child development programs
for preterm or LBW infants, should be a primary objective of
care for these women. Several models of care coordination
and service integration have been developed [71, 72]. One of
the most successful models is the Olds nurse home visitation
program [73]. The program provided nurse home visitation
during pregnancy and the first two years postpartum. Eval-
uation of the Memphis/Shelby County program [73] found
women who received home visits by nurses had fewer closely
spaced subsequent pregnancies, longer internatal intervals,
and fewer months of using public assistance programs, com-
pared to a control group of women. There were, however, no
statistically significant program effects on LBW or stillbirth
in the subsequent pregnancy. The program is technically not
an “internatal care” program and not targeted specifically to
women who had a preterm birth, but this model could poten-
tially be adapted by Healthy Start or other public health or
community-based programs to provide service coordination
and integration for internatal care using community nurses.
We recommend that all women with prior preterm birth be
offered care coordination and/or home visitation during in-
ternatal care.
Schedule of visits
The schedule of internatal visits for women with prior
preterm birth needs to be individualized (with a minimum of
three visits plus annual visits, as previously described), de-
pending on the clinical and psychosocial needs of the woman
and family. During their subsequent pregnancy, these women
should be supervised by a maternal fetal medicine specialist,
either directly or indirectly through consultations.
In sum, given the large impact of preterm birth on in-
fant mortality and childhood disabilities and the high rates
of recurrence in a subsequent pregnancy, women with prior
preterm birth could be one of the most critical target groups
for enhanced internatal care. Other high-risk women (e.g.
women with prior fetal death), could also benefit from such
program; we are unable to describe the content of their care
in this paper due to space limitation and will do so in a
series of papers to follow. The goal of such program is to
prevent recurrence of preterm birth by addressing known
biobehavioral pathways (e.g. infections/inflammation, neu-
roendocrine, vascular, etc) prior to the next pregnancy. There
is a great need for more comprehensive and systematic risk
assessment and health promotion during internatal care, as
well as more basic, clinical and intervention research to iden-
tify effective clinical and psychosocial interventions for the
prevention of recurrent preterm birth.
Conclusion
In this paper, we began to define the contents of internatal
care. We recommended expanding the current six-week post-
partum visit to three or more internatal visits (at two weeks,
six weeks, and six months postpartum, and annual visits
beginning at one-year postpartum). We suggested some core
contents that all women should receive during internatal care,
including risk assessment (e.g. FINDS), health promotion
(e.g. BBEEFF), clinical and psychosocial interventions. For
women with chronic health conditions such as hypertension,
diabetes, or weight problems, we identified clinical guide-
lines for their evaluation, treatment, and follow-up during
the internatal period. For women who had a preterm birth,
we proposed an internatal care model based on known eti-
ologic pathways, with the goal of preventing recurrence by
addressing these biobehavioral pathways prior to the next
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pregnancy. We suggested enhancing service integration for
women and families, including possibly care coordination or
home visitation for women with prior preterm birth.
We were limited in our effort to define the contents of
internatal care by the paucity of research on the internatal
period. Many pre-disease pathways leading to recurrence of
adverse birth outcomes have not yet been elucidated. More
importantly, even less is known about the trajectories to long-
term women’s health or child health, or how to alter these
pathways and trajectories. There is a need for more inter-
vention studies evaluating the effectiveness of the various
components of internatal care. More importantly, we need
more research on mechanisms of disease to guide the de-
sign of internatal interventions. Our proposal will need to
be updated and revised continually as new research data
emerge.
We were also limited by the paucity of research on
community-level or public health interventions during the
internatal period. While our paper focused on the contents of
the clinical visits, we believe that provision of internatal care
should not be limited to the clinician’s office. For example,
clinical interventions to control hypertension may be more
effective if they are supported by community-level or public
health interventions, such as implementation of the American
Public Health Association resolution that the food manufac-
turers and restaurants reduce sodium in the food supply by
50 percent over the next decade [37]. The 5A’s of smoking
cessation may be more effective if they are supported by mul-
tilevel interventions at the interpersonal (e.g. targetting part-
ner smoking), community and institutional (e.g. billboards
and marketing of tobacco products, access to smoking ces-
sation programs), and policy levels (e.g. ban on smoking in
public space, promotion of smoke-free environments, and in-
creased taxation on tobacco products) [3]. We believe that the
ultimate success of internatal care may hinge on the develop-
ment of a much broader and more integrated conception of
internatal care than currently prevails with prenatal care [2].
Presently there are numerous public health programs of-
fering some components of internatal care, including many
Healthy Start programs. They could provide the ideal social
laboratory settings for implementing and evaluating various
community-level interventions. While there are significant
challenges to this type of research, it needs to be done. Iden-
tifying what internatal interventions work in the community
may be just as important as identifying what works in the
clinical setting. Such research needs to be guided by the
principles and methods of community-based participatory
research (CBPR) [74] and be held to scientifically rigorous
standards.
Although more research is needed to identify effec-
tive internatal interventions, we believe we cannot wait
for the perfect studies to be done. We must begin to act.
Most of our recommendations can be justified on the ba-
sis of providing good preventive and primary care for
women and children, even in the absence of conclusive ev-
idence supporting their effectiveness in improving subse-
quent pregnancy outcomes. For the most part they reflect
current practice standards recommended by major national
organizations (Table 1); most of these are considered stan-
dards of care or best practices in women’s and children’s
health care. The only recommendations without the endorse-
ment of a national organization–screening for psychosocial
stress and provision of psychosocial support–are based on
our collective opinions; we strongly believe these are impor-
tant to reduce allostatic load on women’s health and improve
subsequent pregnancy outcome. In this paper we did not
attempt to address all the institutional components and chal-
lenges in developing a successful model of internatal care,
only the content of such a program. This paper reflects our
effort to start the process of defining the contents of internatal
care. We hope that this paper can be used to stimulate further
dialogues about internatal care. Such dialogues, we believe,
are needed to move forward research, practice, and policy on
internatal care, and to move this nation one step closer toward
the provision of a more universal, longitudinally-integrated
continuum of women’s healthcare.
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